MedCap has been growing earnings at an average annual rate of 22.5%, while the Life Sciences industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 19.8% per year. MedCap's return on equity is 14.8%, and it has net margins of 10.4%.
Key information
22.51%
Earnings growth rate
22.27%
EPS growth rate
Life Sciences Industry Growth
26.83%
Revenue growth rate
19.84%
Return on equity
14.79%
Net Margin
10.35%
Next Earnings Update
21 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How MedCap makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:61MA Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
2,176
225
813
0
31 Dec 25
2,110
220
792
0
30 Sep 25
1,996
197
764
0
30 Jun 25
1,908
199
736
0
31 Mar 25
1,844
202
720
0
31 Dec 24
1,807
207
699
0
30 Sep 24
1,791
228
674
0
30 Jun 24
1,742
214
655
0
31 Mar 24
1,671
203
624
0
31 Dec 23
1,589
172
601
0
30 Sep 23
1,466
150
562
0
30 Jun 23
1,343
149
523
0
31 Mar 23
1,241
123
486
0
31 Dec 22
1,124
118
444
0
30 Sep 22
1,056
118
419
0
30 Jun 22
1,017
107
410
0
31 Mar 22
967
102
394
0
31 Dec 21
926
97
385
0
30 Sep 21
896
76
375
0
30 Jun 21
869
64
359
0
31 Mar 21
845
67
339
0
31 Dec 20
828
63
329
0
30 Sep 20
802
55
326
0
30 Jun 20
786
53
317
0
31 Mar 20
763
47
308
0
31 Dec 19
757
55
294
0
30 Sep 19
734
43
288
0
30 Jun 19
740
41
291
0
31 Mar 19
727
32
297
0
31 Dec 18
709
24
298
0
30 Sep 18
716
14
286
0
30 Jun 18
689
8
278
0
31 Mar 18
660
10
268
0
31 Dec 17
617
7
261
0
31 Oct 17
779
11
298
0
31 Jul 17
802
3
301
0
30 Apr 17
853
0
299
0
31 Jan 17
901
5
291
0
31 Oct 16
897
10
276
0
31 Jul 16
874
19
258
0
30 Apr 16
818
20
239
0
31 Jan 16
817
18
232
0
31 Oct 15
818
17
226
0
31 Jul 15
825
8
228
0
Quality Earnings: 61MA has high quality earnings.
Growing Profit Margin: 61MA's current net profit margins (10.4%) are lower than last year (10.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 61MA's earnings have grown significantly by 22.5% per year over the past 5 years.
Accelerating Growth: 61MA's earnings growth over the past year (11.5%) is below its 5-year average (22.5% per year).
Earnings vs Industry: 61MA earnings growth over the past year (11.5%) exceeded the Life Sciences industry 5.4%.
Return on Equity
High ROE: 61MA's Return on Equity (14.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/11 16:28
End of Day Share Price
2026/06/11 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedCap AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.